Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis-Reference-Cited by-同舟云学术

Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis

Published:2017-12-15 Issue:2 Volume:32 Page:181-187
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Ghareghani Majid¹^ORCID,Scavo Linda²³,Arnoult Damien³,Zibara Kazem²,Farhadi Naser¹

Affiliation:

1. Cellular and Molecular Research Center; Faculty of Medicine; Yasuj University of Medical Sciences; Yasuj Iran

2. ER045, PRASE; Laboratory of stem cells, Biology department; Faculty of Sciences; Lebanese University; Beirut Lebanon

3. INSERM U 1197; Laboratory of stem cells, transplantation and immunoregulation; Villejuif France

Funder

Yasuj University of Medical Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12337/fullpdf

Reference24 articles.

1. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis;Haase;NeuroImmunomodulation,2004

2. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage;Reiter;J. Physiol. Pharmacol.,2007

3. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis;Melamud;J. Neurol. Sci.,2012

4. Melatonin-immune system relationships;Guerrero;Curr. Top. Med. Chem.,2002

5. Melatonin: buffering the immune system;Carrillo-Vico;Int. J. Mol. Sci.,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of melatonin supplementation on neurobehavioral outcomes and clinical severity in rodent models of multiple sclerosis; a systematic review and meta-analysis;Inflammopharmacology;2024-01-22

2. Clinical efficacy and safety of melatonin supplementation in multiple sclerosis: a systematic review;Inflammopharmacology;2023-07-10

3. Clinical and biochemical changes and their correction in patients with metabolic phenotype of osteoarthritis and insomnia;Obesity and metabolism;2023-06-06

4. Fighting age-related orthopedic diseases: focusing on ferroptosis;Bone Research;2023-03-01

5. Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis;Experimental & Molecular Medicine;2023-01-13